Related references
Note: Only part of the references are listed.Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis
B. Duxbury et al.
LUPUS (2013)
Interleukin 1β Blockade Improves Signs and Symptoms of Chronic Calcium Pyrophosphate Crystal Arthritis Resistant to Treatment
Andreas P. Diamantopoulos et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2012)
Methotrexate Is an Option for Patients With Refractory Calcium Pyrophosphate Crystal Arthritis
Mariano Andres et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2012)
EULAR recommendations for calcium pyrophosphate deposition. Part II: Management
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Methotrexate-how does it really work?
Edwin S. L. Chan et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure
Nadia Announ et al.
JOINT BONE SPINE (2009)
Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al
Thi Huyen Tran Doan et al.
ARTHRITIS AND RHEUMATISM (2008)
Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis
J. Braun et al.
ARTHRITIS AND RHEUMATISM (2008)
Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease - An exploratory analysis
Amelie Chollet-Janin et al.
ARTHRITIS AND RHEUMATISM (2007)
Genetic studies of chondrocalcinosis
Y Zhang et al.
CURRENT OPINION IN RHEUMATOLOGY (2005)
Share Paper
